Wednesday, November 30, 2022
News

SK Bioscience suspends production of COVID-19 vaccine 'Sky Covione'

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Others | November 24, 2022 9:29:54 AM IST
Seoul [South Korea], November 24 (ANI/Global Economic): SK Bioscience on Wednesday said that it is not producing finished products of Korea's first COVID-19 vaccine "Sky Covione" due to its low vaccination rate.

It previously obtained item approval on June 29 and supplied vaccines on September under a pre-purchase contract with the government, but suspended production due to low market demand.

An official from SK Bioscience said, "Vaccines are produced by dividing into undiluted solutions and finished products, and finished products are supplied according to market demand. Sky Covione is not currently being produced due to low vaccination rate, and we will resume the production when there is a request from the government."

The official added, "We are still waiting for global approvals for overseas sales."

According to data from the Korea Centers for Disease Control and Prevention, only 493 people got the Sky Covione vaccine from the 1st to the 20th of this month. During the same period, 54,711 people got the Pfizer vaccine. Compared to the Pfizer vaccine, the number of people who got the Sky Covione vaccine is significantly low.

Meanwhile, SK Bioscience applied for conditional marketing authorization (CMA) to the UK Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) in July. It also applied for the emergency use authorization (EUA) to the World Health Organization (WHO) in early September to quickly supply vaccines and treatments. However, nothing has been approved yet. (ANI/Global Economic)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE WORLD NEWS
China's security forces mobilise, intens...
'Date is set': India, Australia trade de...
Pakistan policeman among two dead in Que...
Alibaba founder Jack Ma ends up in Japan...
From 400 China's nuke stockpile to swell...
India assumes leadership on world stage ...
More...
 
INDIA WORLD ASIA
Jyotiraditya Scindia inaugurates multipl...
'Criminal justice system itself can be a...
Mehrauli Murder: Aaftab's polygraph test...
3 ex-AAP legislators join BJP ahead of M...
Earthquake of 2.4 magnitude strikes near...
NDTV co-founder Prannoy Roy, wife steps ...
More...    
 
 Top Stories
German Chancellor Scholz planning b... 
Delhi Excise Minister changed phone... 
Popularity brings troubles, side-ef... 
Islamic State group announces death... 
Anti-drone guns deployed at electio... 
Study reveals that diet can reduce ... 
Core industries' growth slows to 0.... 
Uttarakhand Assembly passes strict ...